HOME >> BIOLOGY >> NEWS
Genetic discovery could dramatically reduce need for liver transplants in children

CINCINNATI A new study published in the Journal of Clinical Investigation opens the door to the possibility of new treatments for children who suffer from biliary atresia, a deadly disease of infancy and the most common reason for liver transplantation in children. The new treatments could dramatically reduce the number of liver transplants performed on children every year.

Jorge Bezerra, M.D., a physician/researcher in the Division of Gastroenterology, Hepatology and Nutrition at Cincinnati Children's Hospital Medical Center, and research colleagues at Cincinnati Children's, discovered that in the early phases of biliary atresia, inflammatory genes are activated and control the obstruction of bile ducts in mice. The discovery "substantiates our initial observation in humans and opens the door for the future development of agents to control inflammation and progression of disease," Dr. Bezerra said.

Biliary atresia occurs in infants and usually becomes evident two to eight weeks after birth. Its cause has been unknown. Symptoms include unexplained jaundice, dark urine, clay-colored stools and weight loss. The disease destroys bile ducts in the liver, trapping bile, rapidly causing damage to liver cells and severe scarring.

Biliary atresia accounts for up to 50 percent of children who undergo liver transplantation. Although a surgical procedure is successful in many infants, three of every four children who have biliary atresia need a liver transplant before the age of 20. The total annual cost, including transplant care, of treating all infants with biliary atresia is estimated to be $65 million.

In a previous study published in The Lancet, Dr. Bezerra obtained biopsies of livers of 14 infants with biliary atresia. Using gene chip technology, he and the Cincinnati Children's research team discovered that in the early phases of biliary atresia, inflammatory genes are activated and immunoglobulin genes are suppressed, pointing
'"/>

Contact: Jim Feuer
jim.feuer@cchmc.org
513-636-4656
Cincinnati Children's Hospital Medical Center
2-Aug-2004


Page: 1 2

Related biology news :

1. Genetic mutations linked to the practice of burning coal in homes in China
2. Genetic differences might help distinguish thyroid cancers
3. Genetic modification of linseed produces healthier omega 3 and 6 fatty acids
4. Wiley publishes Welcome to the Genome: A Users Guide to the Genetic Past, Present, and Future
5. Genetically modified bacterium as remedy for intestinal diseases
6. Genetic analysis rewrites salamanders evolutionary history
7. Genetic map of important tree genes outlined
8. Genetically-engineered marathon mouse keeps on running
9. Genetic clues found for common congenital brain disorder
10. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
11. Genetic model for devastating form of paraplegia suggests new treatments

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2020)... ... May 22, 2020 , ... Oxford Nanopore Technologies is ... of SARS-CoV-2, the virus that causes COVID-19. , The LamPORE assay is ... smaller sample numbers, to very large numbers of samples. Hardware and reagents sit ...
(Date:5/21/2020)... ... May 20, 2020 , ... Catalent, the leading global ... and gene therapies, and consumer health products, today announced that Jean-François Chaubard, Senior ... the ISCT 2020 Paris Virtual conference, which takes place on 28 – 29 ...
(Date:5/15/2020)... , ... May 15, 2020 , ... The National Institutes ... property law firm based in Frederick, Maryland and Tysons Corner, Virginia, to provide patent ... biotechnology and a another in the field of chemistry. The firm is one of ...
Breaking Biology News(10 mins):
(Date:5/28/2020)... SILVER SPRING, Md. (PRWEB) , ... May 28, 2020 , ... ... five distinguished biometrics and security leaders as the 2020 winners of the Women ... and co-presented with sponsors IDEMIA , Biometric Update and the ...
(Date:5/21/2020)... MN (PRWEB) , ... May 19, 2020 , ... Experienced ... help patients get dental implants and bone grafting through PIEZOSURGERY® technology. PIEZOSURGERY ... This is often used to prepare a patient for dental implants, especially when the ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... cell banks and hMSC bioprocess systems, today announced the launch of its ... extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with hMSC-EV product ...
(Date:5/15/2020)... ... 15, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel ... Mr. Ganz will continue to lead Sentien’s Board of Directors, a role he ... Brian Miller and Sentien’s management team. , Mr. Ganz has more than ...
Breaking Biology Technology:
Cached News: